|
Country |
Influenza vaccine |
Hepatitis B vaccine |
Pneumococcal vaccine |
Source document (reference) |
|
Belgium |
Persons suffering from
chronic diseases including that of the kidneys. |
Candidates for or patients
already treated by kidney replacement therapy. |
High-risk persons aged >
45 years; renal patients (not further specified) and transplant
recipients are considered as high-risk persons. |
Scientific Institute of
Public Health [1] |
|
Brazil |
Patients with chronic
renal disease, and transplant recipients |
Patients on hemodialysis
or awaiting initiation of hemodialysis; transplant recipients |
Patients with chronic
renal disease, and transplant recipients |
Centro de Vigilancia
Epidemiologica - Divisão de Imunização - Sao Paulo [2] |
|
Canada |
Persons aged
≥ 65 years; adults and children with
chronic conditions, such as diabetes mellitus and other
metabolic diseases, cancer, immunodeficiency, immunosuppression
(due to underlying disease and/or therapy), renal disease,
anemia, and hemoglobinopathy |
Hemodialysis patients (40
µg of vaccine antigen per dose should be used) |
Persons
≥ 75 years of age; persons aged
65-74 years with chronic renal diseases/chronic renal
insufficiency; persons aged ≥ 2
years of age with nephrotic syndrome, or upon commencement of
dialysis; induced immunosuppression for organ transplant or
post-transplantation (bone marrow or stem cell and solid organ
transplants) |
Health Canada [3] |
|
Iceland |
Yearly vaccination
recommended for persons aged > 60 years, children and adults
suffering from chronic diseases of the heart, lungs, kidneys and
liver, and persons with diabetes mellitus, malignancies or other
immunosuppressive diseases. |
Patients on hemodialysis |
Persons aged > 60 years,
persons with chronic disease of the heart, lungs, kidneys and
liver, persons with diabetes, malignancies and other
immunosuppressive diseases. Vaccination generally recommended every 10 years, but every 5
years in patients with immunosuppressive diseases. |
Icelandic Surgeon General
[4] |
|
India
|
In special circumstances
|
At birth |
In special circumstances
|
Indian Medical Association
[5] |
|
Japan
|
Yearly vaccination
recommended for persons aged ≥ 65
years or 60-64 years with activities of daily living that are
severely impaired by disorders of heart, kidney or lung. |
Mandatory for dialysis
patients |
Mandatory vaccination
(once during lifetime). Special recommendation for aged persons,
persons aged > 2 years with chronic heart, liver, lung, or
kidney disease, and persons with diabetes or immune deficiency.
|
Japanese Infectious
Disease Surveillance Center [6] |
|
South Africa |
All persons over the age
of 65 years; persons (adults or children) receiving regular
medical care for conditions such as chronic pulmonary and
cardiac disease, chronic renal diseases, diabetes mellitus and
similar metabolic disorders, and individuals who are
immunosuppressed (including HIV-infected persons with CD4 counts
above 200/ml). |
National policy on
childhood vaccination for hepatitis B; adults in high-risk
occupations; and patients on hemodialysis. |
Persons aged
≥ 65 years; persons aged
≥ 2 years with chronic renal
failure, nephrotic syndrome, organ or bone marrow transplants
and on immunosuppressive therapy. |
National Institute for
Communicable Diseases [7]; Pulmonology Society Working Group
[8]; and South African Renal Society [9] |
|
United Kingdom |
Chronic medical conditions
(respiratory, heart, renal, liver disease, and diabetes) |
Hemodialysis patients |
Chronic medical conditions
(respiratory, heart, renal, liver disease, and diabetes) |
Department of Health [10] |
|
USA |
Persons aged
≥ 65 years; adults and children who
have required regular medical follow-up or hospitalization
during the preceding year because of chronic metabolic diseases
(including diabetes mellitus), renal dysfunction |
Universal vaccination of
infants; Hepatitis B vaccination is recommended for all children
and adolescents aged < 19 years; persons aged
≥20 years pre-dialysis (immunogenicity
might depend on degree of renal insufficiency) or
dialysis-dependent |
Persons aged 2-64 years
who have chronic illness; immunocompromised persons aged
≥ 2 years, including persons with
chronic renal failure and nephrotic syndrome. |
Advisory Committee on
Immunization Practices of the Centers for Disease Control and
Prevention [11] |
Acknowledgments: The workgroup co-chairs wish to thank
members of the workgroup, the entire conference participants,
and outside colleagues for their valuable input, including Drs.
Sanjay K. Agarwal (India), Sharon P. Andreoli (USA), Emmanuel
Burdman (Brazil), Barbara Fivush (USA), Ólafur Skúli Indriðason
(Iceland), Kunitoshi Iseki (Japan), Vivekanand Jha (India),
Gillian de Jong (South Africa), Ivor J. Katz (South Africa),
Jeffrey D. Leiser (USA), Charlie Tomson (United Kingdom), Yusuke
Tsukamoto (Japan), and Raymond Vanholder (Belgium).
Reference List
- Scientific Institute of Public Health.
http://www.iph.fgov.be/flu/NL/HGR_Influenza.pdf 2006.
Ref Type: Report
- Accessed October 25 2006. Centro de Vigilancia
Epidemiologica - Divisão de Imunização - Sao Paulo. 2006.
Ref Type: Electronic Citation
- Accessed October 24 2006. Health Canada. 2006.
Ref Type: Electronic Citation
- Icelandic Surgeon General.
http://landlaeknir.is/template1.asp?pageid=202 10-19-2006.
Ref Type: Electronic Citation
- Indian Medical Association.
http://www.imanational.com/PH0.htm 10-19-2006.
Ref Type: Electronic Citation
- Japanese Infectious Disease Surveillance Center.
http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou09/pdf/01.pdf
10-19-2006.
Ref Type: Electronic Citation
- Schoub B: Recommendations pertaining to the use of viral
vaccines: influenza 2006. S Afr J Med 96:103, 2006
- SAMA-SA Pulmonology Society Working Group: Adult
pneumococcal vaccination guideline. S Afr Med J 89:1222-1230,
1999
- Moosa M, Naicker S, Naiker I et al.: Guidelines for the
optimal care of patients on chronic dialysis in South Africa.
SARS Chronic Dialysis Guidelines, 2005
- Department of Health. Immunisation Against Infectious
Disease 1996 - "The Green Book". 1996.
Ref Type: Report
- Centers for Disease Control and Prevention. Advisory
Committee on Immunization Practices.
http://www.cdc.gov/nip/publications/acip-list.htm#Vaccine
10-19-2006.
Ref Type: Electronic Citation
|